-
公开(公告)号:US20080293720A1
公开(公告)日:2008-11-27
申请号:US12096185
申请日:2006-12-04
IPC分类号: A61K31/44 , C07D213/30 , A61K31/4439 , C07D417/02 , C07D401/02 , A61K31/4545 , A61K31/496 , A61K31/5377 , C07D413/02
CPC分类号: C07D213/76 , C07D213/30 , C07D213/78 , C07D213/80 , C07D401/12 , C07D405/12 , C07D405/14 , C07D409/12 , C07D409/14 , C07D413/12 , C07D417/04 , C07D417/12 , C07D453/02 , C07D471/04
摘要: The present invention relates to compounds of following formula: or pharmaceutically acceptable salts thereof; pharmaceutical compositions containing them, and their use in the treatment of disorders mediated by the CCR-2 receptor.
摘要翻译: 本发明涉及下式的化合物或其药学上可接受的盐; 含有它们的药物组合物及其用于治疗由CCR-2受体介导的病症的用途。